Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Cash from Investing (TTM): -8.918M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -8.918M |
| June 30, 2023 | 37.55M |
| March 31, 2023 | -156.30M |
| December 31, 2022 | -169.45M |
| September 30, 2022 | -165.76M |
| June 30, 2022 | -139.59M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.994M |
| December 31, 2021 | -1.006M |
| September 30, 2021 | -0.584M |
| June 30, 2021 | -0.574M |
| March 31, 2021 | -0.14M |
| December 31, 2020 | -0.011M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-169.45M
Minimum
Dec 2022
37.55M
Maximum
Jun 2023
-50.56M
Average
-1.50M
Median
Cash from Investing (TTM) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -160.32M |
| Immunogen Inc (DELISTED) | -1.889M |
| AbbVie Inc | -11.10B |
| Assure Holdings Corp | -0.471M |
| Harpoon Therapeutics Inc (DELISTED) | 3.283M |